
OptimizeRx Corporation
OptimizeRx Corporation (OPRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OPRX · as of Jun 8, 2026
Key Statistics
Explore OptimizeRx Corporation Data
oprx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 73.3%
The OPRX analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $10.50, representing +102.70% upside from the current price of $5.18.
Competitors & Peers
oprx competitorsStock Performance
Full HistoryAbout OptimizeRx Corporation
OptimizeRx Corporation a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications incl…
what is optimizerx corporation · oprx stock overview · optimizerx corporation company profile · who is optimizerx corporation ceo · oprx NASDAQ · optimizerx corporation headquarters · optimizerx corporation business segments
About Stock Overview & Key Data
OptimizeRx Corporation (OPRX) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Nov 28, 2007. As of the latest trading session, OPRX stock price is $5.18, with a market capitalization of $97.0M. The stock has returned -64.97% over the past 12 months and -57.83% year-to-date.
According to 15 Wall Street analysts, the consensus rating for OptimizeRx Corporation stock is Buy, with an average 12-month price target of $10.50. In fiscal year 2025, OptimizeRx Corporation reported revenue of $109.4M and net income of $5.1M. For detailed data — including OptimizeRx Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, OptimizeRx Corporation (OPRX) stock price is $5.18. The stock is traded on NASDAQ under the ticker symbol OPRX. The 52-week range is $4.57 – $22.25.